{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:47:22Z","timestamp":1783720042670,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82300235"],"award-info":[{"award-number":["82300235"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Municipal Health Commission Talent Plan Youth Project","award":["2022YQ031"],"award-info":[{"award-number":["2022YQ031"]}]},{"name":"Sanhang Talent program of Naval medical university","award":["25TPSL0003"],"award-info":[{"award-number":["25TPSL0003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06680-9","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:28:32Z","timestamp":1761092912000},"page":"6045-6051","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concurrent NPM1::CCDC28A and BCR::ABL1 fusions in extramedullary blast crisis of chronic myeloid leukemia: A case report and literature review"],"prefix":"10.1007","volume":"104","author":[{"given":"Ling","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"issue":"20","key":"6680_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood"},{"issue":"8060","key":"6680_CR2","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/s41586-025-08817-2","volume":"640","author":"AE Kamizela","year":"2025","unstructured":"Kamizela AE (2025) Timing and trajectory of BCR::ABL1-driven chronic myeloid leukaemia. Nature 640(8060):982\u2013990","journal-title":"Nature"},{"issue":"2","key":"6680_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2214\/ajr.178.2.1780319","volume":"178","author":"A Guermazi","year":"2002","unstructured":"Guermazi A (2002) Granulocytic sarcoma (chloroma): imaging findings in adults and children. AJR Am J Roentgenol 178(2):319\u2013325","journal-title":"AJR Am J Roentgenol"},{"issue":"22","key":"6680_CR4","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/cncr.30864","volume":"123","author":"P Jain","year":"2017","unstructured":"Jain P et al (2017) Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: cohort study of 477 patients. Cancer 123(22):4391\u20134402","journal-title":"Cancer"},{"issue":"12","key":"6680_CR5","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1080\/10428190600967196","volume":"47","author":"S Paydas","year":"2006","unstructured":"Paydas S, Zorludemir S, Ergin M (2006) Granulocytic sarcoma: 32 cases and review of the literature. Leuk Lymphoma 47(12):2527\u20132541","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"6680_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/DAD.0000000000001897","volume":"43","author":"J Qi","year":"2021","unstructured":"Qi J et al (2021) Extramedullary blast crisis of chronic myelogenous leukemia with a skin lesion: a case report and literature review. Am J Dermatopathol 43(6):450\u2013453","journal-title":"Am J Dermatopathol"},{"issue":"11","key":"6680_CR7","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1038\/s41375-023-02048-y","volume":"37","author":"NCP Cross","year":"2023","unstructured":"Cross NCP et al (2023) European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia. Leukemia 37(11):2150\u20132167","journal-title":"Leukemia"},{"issue":"3","key":"6680_CR8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.6004\/jadpro.2022.13.3.29","volume":"13","author":"LJ Zitella","year":"2022","unstructured":"Zitella LJ (2022) Molecular testing in hematologic malignancies. J Adv Pract Oncol 13(3):324\u2013327","journal-title":"J Adv Pract Oncol"},{"issue":"3","key":"6680_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini B (2005) Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 352(3):254\u2013266","journal-title":"N Engl J Med"},{"key":"6680_CR10","doi-asserted-by":"publisher","unstructured":"Zarka J (2020) Nucleophosmin 1 mutations in acute myeloid leukemia. Genes. https:\/\/doi.org\/10.3390\/genes11060649","DOI":"10.3390\/genes11060649"},{"issue":"7","key":"6680_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrc1885","volume":"6","author":"S Grisendi","year":"2006","unstructured":"Grisendi S et al (2006) Nucleophosmin and cancer. Nat Rev Cancer 6(7):493\u2013505","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"6680_CR12","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1091\/mbc.e13-12-0717","volume":"25","author":"M Poletto","year":"2014","unstructured":"Poletto M (2014) Nucleophosmin modulates stability, activity, and nucleolar accumulation of base excision repair proteins. Mol Biol Cell 25(10):1641\u20131652","journal-title":"Mol Biol Cell"},{"issue":"5","key":"6680_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/leu.2012.356","volume":"27","author":"RA Alharbi","year":"2013","unstructured":"Alharbi RA (2013) The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia 27(5):1000\u20131008","journal-title":"Leukemia"},{"issue":"10","key":"6680_CR14","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1158\/2159-8290.CD-16-0237","volume":"6","author":"MW K\u00fchn","year":"2016","unstructured":"K\u00fchn MW (2016) Targeting chromatin regulators inhibits leukemogenic gene expression in NPM1 mutant leukemia. Cancer Discov 6(10):1166\u20131181","journal-title":"Cancer Discov"},{"issue":"26","key":"6680_CR15","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese G (2014) Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 371(26):2477\u20132487","journal-title":"N Engl J Med"},{"issue":"15","key":"6680_CR16","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood.2019004226","volume":"136","author":"B Falini","year":"2020","unstructured":"Falini B (2020) NPM1-mutated acute myeloid leukemia: from bench to bedside. Blood 136(15):1707\u20131721","journal-title":"Blood"},{"issue":"7","key":"6680_CR17","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and Histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719","journal-title":"Leukemia"},{"issue":"20","key":"6680_CR18","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1182\/bloodadvances.2019000404","volume":"3","author":"N Shiba","year":"2019","unstructured":"Shiba N (2019) Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. Blood Adv 3(20):3157\u20133169","journal-title":"Blood Adv"},{"issue":"25","key":"6680_CR19","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1182\/blood.2021012732","volume":"138","author":"MP Martelli","year":"2021","unstructured":"Martelli MP (2021) Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML. Blood 138(25):2696\u20132701","journal-title":"Blood"},{"issue":"1","key":"6680_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41375-024-02438-w","volume":"39","author":"Y Shimosato","year":"2025","unstructured":"Shimosato Y et al (2025) NPM1-fusion proteins promote myeloid leukemogenesis through XPO1-dependent HOX activation. Leukemia 39(1):75\u201386","journal-title":"Leukemia"},{"issue":"1","key":"6680_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.6004\/jnccn.2024.0007","volume":"22","author":"NP Shah","year":"2024","unstructured":"Shah NP et al (2024) Chronic myeloid leukemia, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 22(1):43\u201369","journal-title":"J Natl Compr Canc Netw"},{"issue":"Supplement 1","key":"6680_CR22","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2023-181456","volume":"142","author":"Z Wen","year":"2023","unstructured":"Wen Z (2023) Flumatinib for newly diagnosed chronic phase chronic myeloid leukemia: an open-label, multi-center study. Blood 142(Supplement 1):3175\u20133175","journal-title":"Blood"},{"key":"6680_CR23","doi-asserted-by":"crossref","unstructured":"Kittai A, Yu EM, Tabbara I (2014) Granulocytic sarcoma in a patient with chronic myeloid leukaemia in complete haematological, cytogenetic and molecular remission. BMJ Case Rep, 2014","DOI":"10.1136\/bcr-2014-207466"},{"issue":"6","key":"6680_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.14740\/jocmr2566w","volume":"8","author":"A Soni","year":"2016","unstructured":"Soni A et al (2016) Extramedullary involvement by chronic myelogeneous leukemia in five patients with unusual clinicopathologic features: a review of the effectiveness of tyrosine kinase inhibitors. J Clin Med Res 8(6):480\u2013485","journal-title":"J Clin Med Res"},{"issue":"5","key":"6680_CR25","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/s41375-024-02204-y","volume":"38","author":"A Brioli","year":"2024","unstructured":"Brioli A (2024) Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet blast phase registry. Leukemia 38(5):1072\u20131080","journal-title":"Leukemia"},{"issue":"12","key":"6680_CR26","first-page":"3965","volume":"109","author":"Y Yang","year":"2024","unstructured":"Yang Y et al (2024) Safety and efficacy of Flumatinib as later-line therapy in patients with chronic myeloid leukemia. Haematologica 109(12):3965\u20133974","journal-title":"Haematologica"},{"issue":"1","key":"6680_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/1078-0432.CCR-20-1600","volume":"27","author":"L Zhang","year":"2021","unstructured":"Zhang L (2021) Flumatinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: a phase III, randomized, open-label, multi-center festnd study. Clin Cancer Res 27(1):70\u201377","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06680-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T02:31:30Z","timestamp":1764729090000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06680-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["6680"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06680-9","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Formal ethical approval for a single-patient case report was waived by the Institutional Review Board, because all identifying details were removed. Written informed consent was obtained from the patient for inclusion in the study and for publication of the anonymised clinical data and images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics and consent to publish"}}]}}